734 filings
Page 9 of 37
8-K
z07j pyre7fpm7w
7 Dec 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock
12:00am
8-K
c458k30wj0xw0d
28 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
4l4hvq3 21fch
20 Nov 17
Departure of Directors or Certain Officers
12:00am
DEFA14A
7qa35r9djphgxazb8a
13 Nov 17
Additional proxy soliciting materials
12:00am
8-K
ky24euclzh2tm1cj
13 Nov 17
Peregrine Announces Date of 2017 Annual Meeting of Stockholders
12:00am
DFAN14A
q573ug2z
30 Oct 17
Additional proxy materials by non-management
12:00am
DFAN14A
zrtl6r54zi0v6b09l4dv
30 Oct 17
Additional proxy materials by non-management
12:00am
DFAN14A
9k9syy
27 Oct 17
Additional proxy materials by non-management
12:00am
DEFA14A
qzcll klz8sd
24 Oct 17
Additional proxy soliciting materials
12:00am
8-K
j5c6iwaoxv4 1cz4
24 Oct 17
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
12:00am
DEFA14A
3huwb9ly h2wvlagjzf
23 Oct 17
Additional proxy soliciting materials
12:00am
8-K
x1oa ff5fd
23 Oct 17
Departure of Directors or Certain Officers
12:00am
DEFA14A
7td4uhvorbho60 rz
19 Oct 17
Additional proxy soliciting materials
12:00am
8-K
53jged u32i
19 Oct 17
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
12:00am
DFAN14A
nyp1efievfvmph
10 Oct 17
Additional proxy materials by non-management
12:00am
8-K
ynmoktzm86hroqhaq
14 Sep 17
Departure of Directors or Certain Officers
12:00am
DEFA14A
p9okj8zwdy1szf6ot
14 Sep 17
Additional proxy soliciting materials
12:00am
8-K
1p7p 9hcsv
11 Sep 17
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices
12:00am
8-K
n342ar 3elefv5vq3dtt
11 Sep 17
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments
12:00am
DEFA14A
9nwuczi eb
11 Sep 17
Additional proxy soliciting materials
12:00am